Lancella Laura, Abate Luciana, Cursi Laura, Chiopris Giulia, Nicoletti Laura, Principi Nicola, Villani Alberto, Esposito Susanna
Academic Department of Pediatrics (DPUO), Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Microorganisms. 2023 Mar 12;11(3):730. doi: 10.3390/microorganisms11030730.
Tuberculosis remains (TB) to be one of the most common causes of child morbidity and mortality. Abdominal TB is not frequently diagnosed and, although its incidence is not definitively established, there are data that seem to indicate that it accounts for approximately 1-3% of all pediatric TB cases and for no more than 10% of those with extrapulmonary manifestations. It seems, however, that abdominal TB is significantly more common than usually thought as signs and symptoms are non-specific and may mimic other diseases. The delayed or wrong diagnosis of pediatric abdominal TB can have dramatic consequences as they can lead to untreated TB with miliary dissemination, unnecessary surgery, or dangerous drug therapies. This report describes five cases of abdominal TB diagnosed among 216 pediatric patients admitted for TB in Italy from 2011 to 2021. Our cases evidence that abdominal TB is a complex and potentially very severe disease that, when not appropriately diagnosed, may be associated with severe complications and prolonged anti-TB therapy. Discussion among specialists is crucial to achieve an early diagnosis and to promptly start the anti-TB treatment. Further studies are needed to clarify the appropriate duration of therapy as well as management of MDR abdominal TB cases.
结核病仍然是儿童发病和死亡的最常见原因之一。腹部结核病并不常被诊断出来,尽管其发病率尚未明确确定,但有数据似乎表明,它约占所有儿童结核病病例的1-3%,在肺外表现的病例中占比不超过10%。然而,由于腹部结核病的症状和体征不具特异性,可能会与其他疾病相似,所以它似乎比通常认为的更为常见。儿童腹部结核病的诊断延迟或错误可能会产生严重后果,因为这可能导致未经治疗的结核病出现粟粒性播散、不必要的手术或危险的药物治疗。本报告描述了2011年至2021年在意大利因结核病住院的216例儿科患者中诊断出的5例腹部结核病病例。我们的病例证明,腹部结核病是一种复杂且可能非常严重的疾病,如果诊断不当,可能会伴有严重并发症和长期抗结核治疗。专家之间的讨论对于早期诊断和及时开始抗结核治疗至关重要。需要进一步研究以明确适当的治疗时长以及耐多药腹部结核病病例的管理。